Our Studies

To date, we have successfully completed over 500 FDA-approved studies in the areas of allergy, asthma and immunological diseases. At any given time, we are running numerous studies, advancing the frontiers of research and the possibilities of treatments every day.

CURRENT STUDIES

To apply to participate in one of our studies, please go here. If you would like to participate in a specific study, please note that when you fill out our survey.

DBV – Child Peanut Patch Study

Study Treatment: Peanut Patch
Subjects: 1-3 years of age with peanut allergy

For full information go to this link in clinicaltrials.gov

Sanofi – Adult Peanut SLIT

Study Treatment: Peanut Sublingual Immunotherapy plus adjuvant
Subjects: 18 years and above with peanut allergy

For full information go to this link in clinicaltrials.gov

Regeneron – Child Peanut OIT Study

Study Treatment: Dupilumab and peanut oral immunotherapy
Subjects: 6-17 years of age with peanut allergy

For full information go to this link in clinicaltrials.gov

UW – Adult Allergies and Asthma study

Study Purpose: Study being conducted in collaboration with the University of Washington identifying why some people with allergies have asthma and other do not
Subjects: 18 years and above with asthma and/or allergies

DONATE

Amphastar – Adult Asthma Study

Study Treatment: Albuterol generic vs. name brand
Subjects: 18 years and above with moderate persistent asthma

 

ONGOING STUDIES
(NO FURTHER ENROLLMENT)

  • DBV MILES

  • DBV REALISE

  • DBV PEPITES/PEOPLE

  • Aimmune Palisade ARC003/004

  • Aimmune Ramses ARC007/011

  • Aimmune Rollover ARC008

  • Regeneron R668-ALG-16115

  • Hal Allergy HAL-MPE1/0049

  • Astellas MATRIX